Guidelines for Diagnosis and Management of Iron Deficiency without Anemia

Diagnostic Criteria According to Inflammation Status

• In patients without evidence of inflammation, a serum ferritin < 30 µg/L is considered an appropriate diagnostic threshold for iron deficiency. 1, 2
• In the presence of inflammation, a serum ferritin up to 100 µg/L can still indicate iron deficiency because ferritin behaves as an acute‑phase reactant. 1, 2
• When ferritin is 30–100 µg/L together with a transferrin saturation < 20 %, true iron deficiency is likely even if anemia of chronic disease co‑exists. 1, 2
• An elevated C‑reactive protein (CRP) signals inflammation and therefore modifies the interpretation of ferritin levels. 1, 2

Minimum Diagnostic Evaluation

• Perform a complete blood count with mean corpuscular volume (MCV) to assess for microcytosis. 1, 2
• Include a reticulocyte count to differentiate iron deficiency from other causes of anemia. 1, 2
• Measure serum ferritin as the primary index of iron stores. 1, 2
• Calculate transferrin saturation (serum iron ÷ total iron‑binding capacity × 100) to evaluate circulating iron availability. 1, 2
• Obtain CRP or erythrocyte sedimentation rate (ESR) to detect concurrent inflammation. 1, 2
• An elevated red‑cell distribution width (RDW) can be helpful when micro‑ and macro‑cytosis coexist. 1, 2

Indications for Treating Iron Deficiency without Anemia

• Iron deficiency should be treated even in the absence of overt anemia because it causes fatigue, cognitive impairment, restless‑leg‑like symptoms, exercise intolerance, and headache, all of which diminish quality of life. 3
• Iron is essential for all body cells, not solely for erythropoiesis. 3
• Clinical symptoms of iron deficiency improve after iron supplementation. 3
• In inflammatory bowel disease, isolated iron deficiency may be the only marker of active disease. 3

Oral Iron Therapy – First‑Line Regimen

• Ferrous sulfate 200 mg (≈65 mg elemental iron) once daily is recommended for its effectiveness and low cost. 4
• Once‑daily dosing is superior to multiple daily doses because hepcidin remains elevated for ~48 h after an iron dose, blocking additional absorption and increasing side‑effects without improving efficacy. 4
• Take the dose on an empty stomach for optimal absorption; if gastrointestinal intolerance occurs, it may be taken with food. 4
• Add vitamin C 500 mg with each iron dose to markedly enhance absorption, especially when transferrin saturation is very low. 4
• Avoid tea or coffee for at least 1 hour after the iron dose to prevent absorption inhibition. 4
• If ferrous sulfate is not tolerated, ferrous fumarate (≈106 mg elemental iron) or ferrous gluconate (≈38 mg elemental iron) are acceptable alternatives, though generally more expensive. 4
• Alternate‑day dosing can improve tolerability while providing comparable iron absorption. 4

Monitoring and Duration of Oral Therapy

• Check hemoglobin and ferritin at 4 weeks; ferritin should show a significant rise. 4
• Continue oral iron for 3 months after ferritin normalizes (target > 30 µg/L without inflammation, > 100 µg/L with inflammation) to fully replenish stores. 3, 4
• Re‑measure ferritin every 3 months during the first year, then every 6–12 months thereafter. 3

Indications for Intravenous Iron

Absolute Indications

• Intolerance to at least two different oral iron formulations. 4
• Active inflammatory bowel disease (clinical activity) where inflammation‑induced hepcidin markedly impairs oral absorption. 3, 4
• Post‑bariatric surgery patients due to compromised duodenal absorption. 4
• Failure of ferritin to improve after 4 weeks of adherent oral therapy. 4

Relative Indications

• Celiac disease with inadequate response to oral iron despite strict gluten‑free diet adherence. 4
• Chronic heart failure with iron deficiency (ferritin < 100 ng/mL or 100–300 ng/mL with transferrin saturation < 20 %); IV iron improves symptoms and quality of life. 4
• Chronic kidney disease with functional iron deficiency (ferritin 100–300 ng/mL with transferrin saturation < 20 %). 4
• Ongoing gastrointestinal blood loss that exceeds the replacement capacity of oral iron. 4

Preferred Intravenous Iron Formulations

• Avoid iron dextran as first‑line because it carries a higher risk of true anaphylaxis (≈ 0.6–0.7 %). 4
• True anaphylactic reactions to any IV iron are very rare; most adverse events are pseudo‑allergic complement‑mediated reactions that resolve with slower infusion rates. 4

Prevention of Recurrence

• After successful treatment, restart iron supplementation when ferritin falls below 100 µg/L to prevent relapse. 3
• Rapid recurrence of iron deficiency in asymptomatic patients should raise suspicion for subclinical inflammatory activity. 3
• Treat the underlying disease (e.g., IBD, heart failure) as a cornerstone of recurrence prevention. 3

Critical Errors to Avoid

• Do not prescribe multiple daily oral iron doses; hepcidin‑mediated absorption blockade makes this ineffective and increases side‑effects. 4
• Do not discontinue iron when ferritin normalizes; continue for an additional 3 months to fully restore iron stores. 4
• Do not persist with oral iron beyond 4 weeks without ferritin improvement; reassess adherence, malabsorption, or ongoing loss and consider IV iron. 4
• Do not omit vitamin C supplementation when the oral response is suboptimal. 4
• Do not overlook identification and treatment of the underlying cause of iron deficiency while providing supplementation. 4